KATIE CAMPOS: Open Payments
NPI 1841795804 · MOSCOW, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 18 payments from 6 companies in 2025. Trend: 2023 $498 · 2024 $352 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $261 |
| Novo Nordisk Inc | 3 | $71 |
| Astellas Pharma US Inc | 2 | $63 |
| Medtronic, Inc. | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: AIRSUPRA, Rybelsus, Veozah, FARXIGA, MINIMED 780G, GVOKE HYPOPEN, INCEPTIV, BREZTRI.
Industry payments across ID — which companies pay providers there.
